Candidiasis in Medical News

FDA Approves Additional Indication for Astellas' MYCAMINE(R)

... was approved in 2005 for the treatment of patients with esophageal candidiasis and is the only echinocandin approved for the prophylaxis of Candida ... Peritonitis and Abscesses; for the treatment of patients with Esophageal candidiasis and the prophylaxis of Candida Infections in patients undergoing ...

Breast Cancer Drug May Beat Fungal Infection

... another way to help these critically ill patients." More information The U.S. Centers for Disease Control and Prevention has more about candidiasis . -- Kevin McKeever SOURCE: University of Rochester Medical Center, news release, July 20, ...

Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn's Disease

... infection should be initiated prior to CIMZIA use. Invasive fungal infections, including histoplasmosis , coccidioidomycosis , candidiasis , aspergillosis , blastomycosis , and pneumocystosis . Patients with histoplasmosis or other invasive fungal infections may present ...

Strativa Pharmaceuticals Provides Product Pipeline Update

... Rx a total of $3.5 million for the completion of certain milestones. Loramyc (R) (miconazole Lauriad) for the treatment of oropharyngeal candidiasis (OPC) After preliminary review, the FDA has informed BioAlliance Pharma, Strativa's development partner, that the agency did not accept its NDA ...

Vusion Baby Bottom Line Report: Many Moms Don't Know that Their Babies' Irritated Skin Could Indicate a Severe Diaper Rash that Requires Medical Treatment

... area by a baby's stool. A microscopic evaluation is needed to determine if a baby is suffering from Diaper Dermatitis complicated by documented candidiasis (DDCC). Treating DDCC, along with a regimen of cleansing and frequent diaper changes, may require the use of a prescription skin medication. ...

New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients

... with prolonged neutropenia from chemotherapy. In October 2006, the FDA approved NOXAFIL Oral Suspension for the treatment of oropharyngeal candidiasis (OPC), including infections refractory to itraconazole and/or fluconazole. OPC is a fungal infection of the mouth and throat caused by the yeast ...

Anti-Retroviral Therapies Associated with Reduced Infections in HIV-Infected Children

... herpes zoster (IR, 1.11), dermatophyte infections (IR, 0.88), and oral candidiasis (IR, 0.93). Infection rates were significantly lower than those reported ... pneumonia (IR, 11.1), bacteremia (IR, 3.3), herpes zoster (IR, 2.9), oral candidiasis (IR, 1.2) and tuberculosis (IR, 0.2). “Despite these current ...

Fight against Fungus - A new ray of hope

... a disease called candidiasis. Patients who are most vulnerable to candidiasis are those who are HIV-positive, those who have received organ transplants ... hospital set-up. The drug, which has not yet been approved for use in candidiasis patients, due to its high cost will be reserved for the sickest kinds of ...

New Anti Fungal Drug Eraxis as Good as the Older Medicine

... but they can be life-threatening for people who are already ill and for babies who are born pre-term and tiny. The first compound used to treat candidiasis (yeast infection) was amphotericin B, which was effective but was limited by side effects. Over the years, less toxic alternatives were developed ...

Cancer patients can now take once daily medication for infections

... and neck cancer who are undergoing radiation// therapy can now take once a day medication to fight oropharyngeal candidiasis. Oropharyngeal candidiasis is a fungal infection in the mouth caused by the yeast Candida. This condition is also called thrush. The symptoms of the disease are the formation ...

Cure For Persistent Oral Fungal Problem May Be Possible

... Even active in very low concentrations, when used with inhibitors, the peptide killed the fungal agents that cause very common infections like candidiasis and cryptococcosis. These can be an especially effective treatment for patients having immunity suppressing drugs, like those suffering from ...

Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries

... reporters at a press conference. Many patients stricken with AIDS develop complication of fungal origin. Two common conditions are esophageal candidiasis and cryptococcal meningitis. Flucanazole, commerically available as Diflucan is used to treat these conditions. Representatives of Pfizer Inc. ...

Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries

... reporters at a press conference. Many patients stricken with AIDS develop complication of fungal origin. Two common conditions are esophageal candidiasis and cryptococcal meningitis. Flucanazole, commerically available as Diflucan is used to treat these conditions. Representatives of Pfizer Inc. ...